23andMe is laying off 40 percent of its employees, or over 200 workers, as the company attempts to recover from last year’s ...

The familial trend, it turned out, was linked to a genetic mutation. That meant Bill might also be at risk for the disease.

A new study led by Genomics England and Queen Mary University of London estimates that genetic testing could identify ...

Recent advances in genetic testing technology have transformed personal health care from general guidelines to precise, ...

DNA-testing service 23andMe is making substantial efforts to nurse its feeble genetic core back to health. The company will ...

The global market for cancer-focused genetic testing services is on a transformative growth trajectory, with projections estimating a market size of USD 8,472.70 million by 2024, and an expected ...

Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...

Adam Brufsky, MD, PhD, professor of medicine at the University of Pittsburgh School of Medicine; Megan Kruse, MD, breast medical oncologist at Cleveland Clinic; and Ruta Rao, MD, professor of medicine ...

Knowles was diagnosed with male breast cancer in 2019, making the announcement to Michael Strahan on "Good Morning America." ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

October is Breast Cancer Awareness Month, and a central Kentucky mother and daughter are sharing their story to help others.